Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LCFA-01 in Healthy Participants for Bacterial Vaginosis Treatment
NCT07514416Phase 1Active, not recruiting
- Sponsor
- Massachusetts General Hospital
- Start
- Apr 2026
- Primary completion
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial in bacterial vaginosis (BV) comparing LCFA-01 with Placebo (2 arms). Primary endpoints: Treatment-Emergent Adverse Events, Clinically significant changes in Physical examinations at Day 14 and 3 more. Started Apr 2026; status: active, not recruiting.
02
Drugs
oleic acid
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on NCT07514416.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07514416.